These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35856053)

  • 21. Guillain-Barré Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report.
    Rossetti A; Gheihman G; O'Hare M; Kosowsky JM
    J Emerg Med; 2021 Dec; 61(6):e141-e145. PubMed ID: 34538679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study.
    Menni C; Klaser K; May A; Polidori L; Capdevila J; Louca P; Sudre CH; Nguyen LH; Drew DA; Merino J; Hu C; Selvachandran S; Antonelli M; Murray B; Canas LS; Molteni E; Graham MS; Modat M; Joshi AD; Mangino M; Hammers A; Goodman AL; Chan AT; Wolf J; Steves CJ; Valdes AM; Ourselin S; Spector TD
    Lancet Infect Dis; 2021 Jul; 21(7):939-949. PubMed ID: 33930320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barré Syndrome.
    Hilts A; Schreiber A; Singh A
    Am J Case Rep; 2022 Aug; 23():e936896. PubMed ID: 35945825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.
    Li X; Raventós B; Roel E; Pistillo A; Martinez-Hernandez E; Delmestri A; Reyes C; Strauss V; Prieto-Alhambra D; Burn E; Duarte-Salles T
    BMJ; 2022 Mar; 376():e068373. PubMed ID: 35296468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barré syndrome?
    Zheng X; Fang Y; Song Y; Liu S; Liu K; Zhu J; Wu X
    Eur J Med Res; 2023 Feb; 28(1):98. PubMed ID: 36841799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guillain-Barré Syndrome following ChAdOx1-S/nCoV-19 Vaccine.
    Maramattom BV; Krishnan P; Paul R; Padmanabhan S; Cherukudal Vishnu Nampoothiri S; Syed AA; Mangat HS
    Ann Neurol; 2021 Aug; 90(2):312-314. PubMed ID: 34114256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guillain-Barré syndrome in Denmark: a population-based study on epidemiology, diagnosis and clinical severity.
    Al-Hakem H; Sindrup SH; Andersen H; de la Cour CD; Lassen LL; van den Berg B; Jacobs BC; Harbo T
    J Neurol; 2019 Feb; 266(2):440-449. PubMed ID: 30536111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 Vaccination a Cause of Guillain-Barré Syndrome? A Case Series.
    Nagdev G; Chavan G; Sahu G; Devasilpa Raju PD
    Cureus; 2022 Oct; 14(10):e30888. PubMed ID: 36465787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sub-acute Onset of Guillain-Barré Syndrome Post-mRNA-1273 Vaccination: a Case Report.
    Nagalli S; Shankar Kikkeri N
    SN Compr Clin Med; 2022; 4(1):41. PubMed ID: 35071987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Rare Case of Guillain-Barré Syndrome following COVID-19 Vaccination.
    Kripalani Y; Lakkappan V; Parulekar L; Shaikh A; Singh R; Vyas P
    Eur J Case Rep Intern Med; 2021; 8(9):002707. PubMed ID: 34671572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS.
    Bellucci M; Germano F; Grisanti S; Castellano C; Tazza F; Mobilia EM; Visigalli D; Novi G; Massa F; Rossi S; Durando P; Cabona C; Schenone A; Franciotta D; Benedetti L
    Front Immunol; 2022; 13():894872. PubMed ID: 35924236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine.
    García-Grimshaw M; Michel-Chávez A; Vera-Zertuche JM; Galnares-Olalde JA; Hernández-Vanegas LE; Figueroa-Cucurachi M; Paredes-Ceballos O; Reyes-Terán G; Carbajal-Sandoval G; Ceballos-Liceaga SE; Arauz A; Valdés-Ferrer SI
    Clin Immunol; 2021 Sep; 230():108818. PubMed ID: 34358692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of COVID-19 vaccine type on Guillain-Barré syndrome: Two cases and a literature review.
    Lee HY; Lien WC
    Hum Vaccin Immunother; 2023 Dec; 19(1):2171231. PubMed ID: 36919452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.
    Greene SK; Rett MD; Vellozzi C; Li L; Kulldorff M; Marcy SM; Daley MF; Belongia EA; Baxter R; Fireman BH; Jackson ML; Omer SB; Nordin JD; Jin R; Weintraub ES; Vijayadeva V; Lee GM
    PLoS One; 2013; 8(6):e67185. PubMed ID: 23840621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine.
    Nasuelli NA; De Marchi F; Cecchin M; De Paoli I; Onorato S; Pettinaroli R; Savoini G; Godi L
    Neurol Sci; 2021 Nov; 42(11):4747-4749. PubMed ID: 34272622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guillain-Barré syndrome in association with COVID-19 vaccination: a systematic review.
    Abolmaali M; Rezania F; Behnagh AK; Hamidabad NM; Gorji A; Mirzaasgari Z
    Immunol Res; 2022 Dec; 70(6):752-764. PubMed ID: 36098903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome.
    Jacobs BC; van den Berg B; Verboon C; Chavada G; Cornblath DR; Gorson KC; Harbo T; Hartung HP; Hughes RAC; Kusunoki S; van Doorn PA; Willison HJ;
    J Peripher Nerv Syst; 2017 Jun; 22(2):68-76. PubMed ID: 28406555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guillain-Barre syndrome 15 days after COVID-19 despite SARS-CoV-2 vaccination.
    Finsterer J
    IDCases; 2021; 25():e01226. PubMed ID: 34290962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review.
    Aladawi M; Elfil M; Abu-Esheh B; Abu Jazar D; Armouti A; Bayoumi A; Piccione E
    Can J Neurol Sci; 2022 Jan; 49(1):38-48. PubMed ID: 33949300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?
    Introna A; Caputo F; Santoro C; Guerra T; Ucci M; Mezzapesa DM; Trojano M
    Clin Neurol Neurosurg; 2021 Sep; 208():106887. PubMed ID: 34418708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.